Skip to content
10-Q

Quarterly Report

ANI PHARMACEUTICALS INC ANIP

0001023024-25-000082

← back to feed
Filed
Aug 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2025 · Jun 30, 2025 20.31M sh
Shares Diluted Q2 2025 · Jun 30, 2025 20.18M sh
Shares Diluted Q2 2025 · Jun 30, 2024 19.32M sh
Shares Diluted Q2 2025 · Jun 30, 2024 19.56M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $10.55M
Stock Repurchased Q2 2025 · Jun 30, 2024 $9.96M
Dividends Paid Q2 2025 · Jun 30, 2025 $813K
Dividends Paid Q2 2025 · Jun 30, 2024 $813K
Capex Q2 2025 · Jun 30, 2025 $6.49M
Capex Q2 2025 · Jun 30, 2024 $9.03M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $110.8M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $35.68M
Long Term Debt Q2 2025 · Jun 30, 2025 $301.48M
Long Term Debt Q2 2025 · Dec 31, 2024 $309.11M
Short Term Debt Q2 2025 · Jun 30, 2025 $13.22M
Short Term Debt Q2 2025 · Dec 31, 2024 $9.17M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $217.8M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $144.86M
Stockholders Equity Q2 2025 · Jun 30, 2025 $436.76M
Stockholders Equity Q2 2025 · Dec 31, 2024 $403.68M
Current Liabilities Q2 2025 · Jun 30, 2025 $236.84M
Current Liabilities Q2 2025 · Dec 31, 2024 $193.68M
Total Liabilities Q2 2025 · Jun 30, 2025 $881.39M
Total Liabilities Q2 2025 · Dec 31, 2024 $855.17M
Current Assets Q2 2025 · Jun 30, 2025 $602.63M
Current Assets Q2 2025 · Dec 31, 2024 $527.68M
Total Assets Q2 2025 · Jun 30, 2025 $1.34B
Total Assets Q2 2025 · Dec 31, 2024 $1.28B
Eps Diluted Q2 2025 · Jun 30, 2025 $0.36
Eps Diluted Q2 2025 · Jun 30, 2025 $1.05
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.14
Eps Diluted Q2 2025 · Jun 30, 2024 $0.70
Eps Basic Q2 2025 · Jun 30, 2025 $0.37
Eps Basic Q2 2025 · Jun 30, 2025 $1.07
Eps Basic Q2 2025 · Jun 30, 2024 −$0.14
Eps Basic Q2 2025 · Jun 30, 2024 $0.71
Sga Expense Q2 2025 · Jun 30, 2025 $81.77M
Sga Expense Q2 2025 · Jun 30, 2025 $158.3M
Sga Expense Q2 2025 · Jun 30, 2024 $52.82M
Sga Expense Q2 2025 · Jun 30, 2024 $100.84M
Rd Expense Q2 2025 · Jun 30, 2025 $16.54M
Rd Expense Q2 2025 · Jun 30, 2025 $27.1M
Rd Expense Q2 2025 · Jun 30, 2024 $7.3M
Rd Expense Q2 2025 · Jun 30, 2024 $17.81M
Net Income Q2 2025 · Jun 30, 2025 $8.55M
Net Income Q2 2025 · Jun 30, 2025 $24.23M
Net Income Q2 2025 · Jun 30, 2024 −$2.29M
Net Income Q2 2025 · Jun 30, 2024 $15.92M
Operating Income Q2 2025 · Jun 30, 2025 $13.89M
Operating Income Q2 2025 · Jun 30, 2025 $40.09M
Operating Income Q2 2025 · Jun 30, 2024 $5.17M
Operating Income Q2 2025 · Jun 30, 2024 $25.48M
Revenue Q2 2025 · Jun 30, 2025 $211.37M
Revenue Q2 2025 · Jun 30, 2025 $408.49M
Revenue Q2 2025 · Jun 30, 2024 $138.04M
Revenue Q2 2025 · Jun 30, 2024 $275.47M